These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy]. Lujf A, Sluga E, Moser K. Wien Klin Wochenschr; 1971 Feb 19; 83(7):109-13. PubMed ID: 5547427 [No Abstract] [Full Text] [Related]
8. Studies on enzymatic activity in serum obtained from muscular dystrophic patients. Yamaji K, Imai H, Esaki K, Tokoro T, Hotta K. Nagoya Med J; 1968 Apr 19; 14(1):55-64. PubMed ID: 5696330 [No Abstract] [Full Text] [Related]
9. An investigation of physical factors influencing the behaviour in vitro of serum creatine phosphokinase and other enzymes. Thomson WH. Clin Chim Acta; 1969 Jan 19; 23(1):105-20. PubMed ID: 5762120 [No Abstract] [Full Text] [Related]
16. [Effect of drug administration on the child with progressive muscular dystrophy]. Nakahara T, Annaka S, Baba T, Kanno M. Iryo; 1969 Oct 19; 23(10):1319-27. PubMed ID: 5364983 [No Abstract] [Full Text] [Related]
17. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases. Mokuno K, Riku S, Matsuoka Y, Sobue I, Kato K. J Neurol Sci; 1984 Mar 19; 63(3):345-52. PubMed ID: 6726277 [Abstract] [Full Text] [Related]
20. [Contribution on the study of pseudohypertrophic muscular dystrophies. II. Pseudohypertrophic muscular dystrophies in females]. Radu H, Stenzel K. Dtsch Z Nervenheilkd; 1969 Mar 19; 196(2):116-35. PubMed ID: 5800953 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]